Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
The other option is a private car (a private clinic)
REDEFINE 4: The Tirzepatide Test The results that attracted the greatest market attention came from REDEFINE 4, an 84-week open-label Phase 3 trial reported in February 2026, in which CagriSema was pitted directly against tirzepatide 15 mg, the highest approved dose of Eli Lillys Zepbound
200 units of 200 mcg each
A 26-week trial with 822 participants showed that it has a 44% greater blood sugar level control than regularly prescribed diabetes medicine
Johnson said by e-mail
US$ 24.36
US$ 23.68
US$ 26.58
US$ 26.75
US$ 28.76
US$ 25.06
US$ 29.79
US$ 22.49
US$ 24.32
